EDTA Chelation Therapy

Trial to Assess Chelation Therapy – Dr Pierre Angier, DO

Trial To Assess Chelation Therapy - Dr Pierre Angier, DO

Today I'm going to talk about the recently completed TACT study—that's the Trial to Assess Chelation Therapy. This was 30 million dollar study (funded by the NIH) that looked at the effectiveness of EDTA chelation. EDTA is a synthetic amino acid that is commonly used by alternative physicians to treat heart disease. Over 100,000 a year receive this treatment. While there are dozens of studies that show chelation to be effective, there has not been a large scale, multi-center study until now.
In November of 2102 at the AHA convention in LA, the lead investigator of the study, Dr. Lamas presented his findings. What followed was a storm of controversy. Now some of this was caused by naysayers, most of whom receive large grants from drug companies , and some of the controversy resulted from the was the way the data was presented.
However, now the dust has settled, let's look at the facts.
There were 1708 participants in the study. All of the patients had already had heart attacks or MIs. They were randomly assigned to receive EDTA chelation or a placebo. Neither the clinicians or the patients knew what was in the IV. This is referred to as a double blind, placebo controlled study, and is considered the best approach to determine the effectiveness of a product.
This slide, from the AHA summarizes the results. Overall, there was an 18% reduction in cardiac events. The major benefits occurred in patients with diabetes, a 39% reduction of cardiac events. Also, patients that had an anterior MI, (the most common type of heart attack) had a 37% reduction. These are huge differences, and in my view justify the use of this therapy, especially since the study showed that chelation is extremely safe (a point often not mentioned by the media).
So who might be a candidate for chelation?
If you have heart disease who want to avoid a procedure like bypass surgery or stents, you might consider this, esp since it is well documented that these procedures do nothing to extend your life.
If you have already had a procedure, you may want chelation to prevent restenosis or clogging of the bypass or stent.
For those of your who have multiple risk factors and a strong family hx of heart disease you want to do everything they can to avoid an MI. You might consider chelation therapy.
If you have poor circulation in your legs, EDTA chelation is well documented to help those with peripheral artery disease.
Will your doctor suggest this therapy? Probably not because it' still considered "alternative". But, you can find a doctor that provides chelation at the ACAM website. You can also learn more at GETWELLfl.com.

Trial To Assess Chelation Therapy - Dr Pierre Angier, DO

Trial to Assess Chelation Therapy - Dr Pierre Angier, DO

Today I'm going to talk about the recently completed TACT study—that's the Trial to Assess Chelation Therapy. This was 30 million dollar study (funded by the NIH) that looked at the effectiveness of EDTA chelation. EDTA is a synthetic amino acid that is commonly used by alternative physicians to treat heart disease. Over 100,000 a year receive this treatment. While there are dozens of studies that show chelation to be effective, there has not been a large scale, multi-center study until now.
In November of 2102 at the AHA convention in LA, the lead investigator of the study, Dr. Lamas presented his findings. What followed was a storm of controversy. Now some of this was caused by naysayers, most of whom receive large grants from drug companies , and some of the controversy resulted from the was the way the data was presented.
However, now the dust has settled, let's look at the facts.
There were 1708 participants in the study. All of the patients had already had heart attacks or MIs. They were randomly assigned to receive EDTA chelation or a placebo. Neither the clinicians or the patients knew what was in the IV. This is referred to as a double blind, placebo controlled study, and is considered the best approach to determine the effectiveness of a product.
This slide, from the AHA summarizes the results. Overall, there was an 18% reduction in cardiac events. The major benefits occurred in patients with diabetes, a 39% reduction of cardiac events. Also, patients that had an anterior MI, (the most common type of heart attack) had a 37% reduction. These are huge differences, and in my view justify the use of this therapy, especially since the study showed that chelation is extremely safe (a point often not mentioned by the media).
So who might be a candidate for chelation?
If you have heart disease who want to avoid a procedure like bypass surgery or stents, you might consider this, esp since it is well documented that these procedures do nothing to extend your life.
If you have already had a procedure, you may want chelation to prevent restenosis or clogging of the bypass or stent.
For those of your who have multiple risk factors and a strong family hx of heart disease you want to do everything they can to avoid an MI. You might consider chelation therapy.
If you have poor circulation in your legs, EDTA chelation is well documented to help those with peripheral artery disease.
Will your doctor suggest this therapy? Probably not because it' still considered "alternative". But, you can find a doctor that provides chelation at the ACAM website. You can also learn more at GETWELLfl.com.

Trial To Assess Chelation Therapy - Dr Pierre Angier, DO
Trial To Assess Chelation Therapy - Dr Pierre Angier, DO
Trial To Assess Chelation Therapy - Dr Pierre Angier, DO
Trial To Assess Chelation Therapy - Dr Pierre Angier, DO
Trial To Assess Chelation Therapy - Dr Pierre Angier, DO

Trial To Assess Chelation Therapy - Dr Pierre Angier, DO

Ancient All-Natural Chinese Secrets Shrink Prostate FAST!

" Discover How These Chinese Herbs Solved My Sexual & Prostate Problems Without Flomax, Viagra Or Any Other Drugs Within 14 Days! "

Stroke Management. Self-Care ( Part 1)

Click Here To Learn More!